The Valley Desk

ArticleFuture oncology (London, England)Published

A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"

14 of 31 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name GSK, Jefferson Health, Sidney Kimmel Medical College, Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
Future oncology (London, England)
Published
Subject terms
Endometrial Cancer; Ruby; Dostarlimab; Primary Advanced Or Recurrent Endometrial Cancer; Dostarlimab Plus Chemotherapy
PubMed ID
38990090
PubMed Central ID
PMC11792817
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal